GlassScriptPhysician profile
Carol E Strickland
NPI 1174752638
$1,911.94
in general payments reported to CMS, 2019-2025
23 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $261 · 2023: $635 · 2024: $394 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,363.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $348.78 | 2022-2025 | Wegovy |
| Abbvie INC. | $299.94 | 2021-2023 | |
| Organon LLC | $234.56 | 2024-2025 | Nexplanon |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.49 | 2022-2023 | Jardiance |
| Urovant Sciences INC | $135.99 | 2021 | |
| Myriad Women'S Health, INC. | $121.61 | 2023 | Myrisk |
| Axsome Therapeutics, INC. | $114.10 | 2024 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.75 | 2023 | Xifaxan |
| Shield Therapeutics INC | $44.65 | 2023-2025 | Accrufer |
| Pfizer INC. | $43.55 | 2024-2025 | |
| Sage Therapeutics, LLC | $38.63 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $32.22 | 2025 | Endosee |
| Exact Sciences Corporation | $31.42 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $29.76 | 2025 | Veozah |
| Intuitive Surgical, INC. | $29.46 | 2023 | Da Vinci Surgical System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $23.53 | 2025 | Slynd |
| Supernus Pharmaceuticals, INC. | $21.37 | 2025 | Qelbree |
| Agile Therapeutics, INC. | $19.88 | 2022 | |
| Scynexis, INC. | $18.34 | 2022 | |
| Convatec INC. | $17.39 | 2024 | |
| Hologic Sales and Service, LLC | $14.19 | 2024 | Acessa Provu System |
| Axonics, INC. | $13.79 | 2023 | Axonics |
| Mylan Pharmaceuticals INC. | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Strickland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.